SCHEMBL29264332

SCHEMBL29264332

CCc1cc(N2CCN(C(=O)OC(C)(C)C)CC2)ccc1N1CCC(=O)NC1=O

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ DDB1 Q16531 7/20 0.51
▸ CRBN Q96SW2 7/20 0.51
▸ MAPT P10636 3/20 0.45
▸ LMNA P02545 2/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ PDK2 Q15119 1/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ HTT P42858 2/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ GPR119 Q8TDV5 2/20 0.40
▸ NAMPT P43490 1/20 0.40
▸ MMP2 P08253 1/20 0.40
▸ MMP13 P45452 1/20 0.40
▸ MMP14 P50281 1/20 0.40
▸ ADAMTS5 Q9UNA0 1/20 0.40
▸ MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30952388 0.88 DDB1 (0.50) DDB1CRBNMAPTLMNAALDH1A1
SCHEMBL30643667 0.87 DDB1 (0.49) DDB1CRBNMAPTLMNAALDH1A1
SCHEMBL25824549 0.86 DDB1 (0.48) DDB1CRBNMAPTLMNAALDH1A1
SCHEMBL31630927 0.85 DDB1 (0.49) DDB1CRBNMAPTLMNAALDH1A1
SCHEMBL25034753 0.84 DDB1 (0.48) DDB1CRBNMAPTLMNAALDH1A1
SCHEMBL31630916 0.84 DDB1 (0.48) DDB1CRBNMAPTLMNAALDH1A1
SCHEMBL22119507 0.84 DDB1 (0.59) DDB1CRBNMAPTLMNAALDH1A1
SCHEMBL29265203 0.82 CRBN (0.55) DDB1CRBNMAPTLMNAALDH1A1
SCHEMBL30525413 0.82 CRBN (0.55) DDB1CRBNMAPTLMNAALDH1A1
SCHEMBL30703627 0.82 DDB1 (0.48) DDB1CRBNMAPTLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118271284-A Estrogen receptor modulators and uses thereof 江苏威凯尔医药科技有限公司 2024-07-02 — — CN disclosed
Send feedback